New fill/finish partnership with BioConnection provides end-to-end drug product development under 1 contract!   Read the press release

1 min read

AAPS - PharmSci 360, October 20-23

AAPS - PharmSci 360, October 20-23

Date: October 20-23, 2024

Location: Salt Palace Convention Center, Salt Lake City, UT - Get directions

Event website: https://aaps2024.eventscribe.net/ 

Don't miss our presentation!

AGC Biologics, Raghu Malapaka, PhD will be presenting during a speaker spotlight on Overcoming Challenges in Manufacturing and Scale-Up of Cell & Gene Therapies.  Join us October 23 at 10:00-11:00am.

Let's chat at the event!

Would you like to talk with one of our team members? Interested in learning more about our global network and capabilities? Click the button below, or email our attending representative to set up a meeting.

REQUEST A MEETING     

 

You can also reach out directly to our expert attending the show

Raghu Malapaka, PhD
Sr. Director, Business Development
Email  me

Explore our AAV & LVV Platforms

BravoAAV™ and ProntoLVV™ are end-to-end platforms offering a proprietary GOI backbone and plug-and-play templates for any project. Our services include proprietary plasmids, in-house analytical panels, master cell banks, pre-qualified processes and fill and finish services.  

Our new templated adeno-associated viral vector platform.

 Learn about Bravo

Our new templated lentiviral vector platform.
 

Learn about our cell and gene therapy services 

Cell Therapy Production and Manufacturing

AGC Biologics’ cell therapy services support every stage of the product journey, from pre-clinical through commercialization. At our Milan and Longmont facilities, we can work with virtually any cell type – including Human Mesenchymal Stem Cells (hMSCs), Exosomes, CD34+, T-Cells, NK Cells, and more.  

Using the latest autologous and allogeneic methods, we help your products meet the exact specifications for patients in a clinical or commercial setting. 

Cell therapy offering 

Viral Vector Production and Manufacturing 

AGC Biologics scientists have two decades of viral vector-based gene therapy expertise and specialize in adeno-associated viral vectors (AAV), lentiviral vectors (LVV), and retroviral vectors (RVV). Our sites in the U.S. and Italy have supported four commercial products. 

Our ready-to-use platform capabilities for AAV and LVV programs are built on cell factories and bioreactors using adherent and suspension processes, designed entirely in-house. 

Viral vector services 

Plasmid DNA (pDNA) Materials 

To support your pDNA needs, AGC Biologics utilizes a customized process based on your specific plasmid and hosting system. We have extensive technical expertise in fermentation, purification, and analytics, and our highly experienced teams routinely manufacture GMP-grade pDNA materials. This work includes starting material for gene therapy, and viral vector manufacturing. 

Plasmid offering

 

Fill out the form below to request a meeting during the event